semaglutide news today 2025 Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit glp-1 news updates november 2025

This anemia is also known as pernicious anemia

Patients (n=281, 56% women, mean age 56 years) had type 2 diabetes of approximately 8 year-duration uncontrolled on metformin with mean baseline HbA1c of 8.3% [4]

FA is a weaker acid that forms looser pairs, allowing peptides to come out at different times and helping to separate similar forms

AMPK signaling in energy control, cartilage biology, and osteoarthritis

Hines is one of relatively few enrollees to have used the new Medicaid benefit, which weight loss doctors in the state say has been hindered by national drug shortages, the states prior authorization process for the drugs, and a lack of marketing